Changying Shi
Nanjing Agricultural University(CN)Nanjing Forestry University(CN)Liaoning University of Traditional Chinese Medicine(CN)LMU Klinikum(DE)China National Administration of Coal Geology(CN)Institute of Grassland Research(CN)Ludwig-Maximilians-Universität München(DE)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Advanced Radiotherapy Techniques, Cancer, Hypoxia, and Metabolism, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials(2015)59 cited
- → Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial(2022)48 cited
- → Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells(2013)45 cited
- → Glycochenodeoxycholic acid induces stemness and chemoresistance via the STAT3 signaling pathway in hepatocellular carcinoma cells(2020)44 cited
- → Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis(2019)37 cited
- → Lenvatinib Plus Programmed Cell Death Protein-1 Inhibitor Beyond First-Line Systemic Therapy in Refractory Advanced Biliary Tract Cancer: A Real-World Retrospective Study in China